Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.30
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
-0.70%
Market Cap 2.18B
Revenue (ttm) 804.88M
Net Income (ttm) -243.85M
Shares Out 76.92M
EPS (ttm) -4.39
PE Ratio n/a
Forward PE n/a
Dividend 0.19 (0.68%)
Ex-Dividend Date Jul 24, 2025
Volume 105,763
Average Volume 112,421
Open 28.30
Previous Close 28.30
Day's Range 27.90 - 28.35
52-Week Range 24.20 - 31.70
Beta 0.38
RSI 48.96
Earnings Date May 6, 2026

About TPE:1762

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DMF or COS, and other API products. It also provides specialty API immunosuppressants, including mycophenolate mofetil, rapamycin, and tacrolimus; deriva... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 198
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1762
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.